93 Results

People

  1. O'Reilly
    O'Reilly
  2. Ladanyi
    Ladanyi
  3. Abdel-Wahab
    Abdel-Wahab
  4. Arcila
    Arcila
  5. Riely
    Riely
  6. Scheinberg
    Scheinberg
  7. Zehir
    Zehir
  8. Berger
    Berger
  9. Castro-Malaspina
    Castro-Malaspina
  10. Childs
    Childs

Groups

  1. Department of Medicine (93)
  2. Tow Center for Developmental Oncology (TCDO) (93)
  3. GSK Faculty (90)
  4. Human Oncology and Pathogenesis Program (51)
  5. Solid Tumor Oncology Division (47)
  6. Hematologic Malignancies, Division of (38)
  7. Center for Hematologic Malignancies (37)
  8. Sloan Kettering Institute Faculty (37)
  9. Pediatrics, Department of (36)
  10. Immunology Program Faculty (28)
  1. "Department of Medicine"
  2. "Tow Center for Developmental Oncology (TCDO) "
  3. "Elsevier Science, Inc."
Formats
  1. Meeting Abstract (47)
  2. Journal Article (45)
  3. Review (1)
Groups
  1. Department of Medicine (93)
  2. Tow Center for Developmental Oncology (TCDO) (93)
  3. GSK Faculty (90)
  4. Human Oncology and Pathogenesis Program (51)
  5. Solid Tumor Oncology Division (47)
  6. Hematologic Malignancies, Division of (38)

More Groups

People
  1. Marc Ladanyi (29)
  2. Richard O'Reilly (27)
  3. Maria Arcila (14)
  4. Ahmet Zehir (11)
  5. Omar Abdel-Wahab (11)
  6. Gregory Riely (9)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2022 (5)
  4. 2021 (5)
  5. 2020 (10)
  6. 2019 (2)

More Years

Publications
  1. Experimental Hematology (26)
  2. Journal of Molecular Diagnostics (26)
  3. Lancet Oncology (9)
  4. European Urology (5)
  5. Lancet (5)
  6. Biochemical and Biophysical Research Communications (4)

More Publications

Publishers
  1. Elsevier Science, Inc. (93)

Results (93)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein–Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): A phase 3, multicentre, open-label trial
    Journal Article

    Mahadeo, K. M.; Baiocchi, R.; Beitinjaneh, A.; Chaganti, S.; Choquet, S.; Dierickx, D.; Dinavahi, R.; Duan, X.; Gamelin, L.; Ghobadi, A.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Intercepting progression to leukemia in a novel RUNX1-FPD mouse model
    Meeting Abstract

    Goto, H.; Todorova, T.; Schwenger, E.; Taylor, S.; Chen, S.; Narayanagari, S. R.; Sun, D.; Bohorquez, O.; Kumari, R.; Sundaravel, S.; more...
    Experimental Hematology (2023)

    Fulltext@MSK | Save
  • Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: A 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium
    Journal Article

    Thakar, M. S.; Logan, B. R.; Puck, J. M.; Dunn, E. A.; Buckley, R. H.; Cowan, M. J.; O'Reilly, R. J.; Kapoor, N.; Satter, L. F.; Pai, S. Y.; more...
    Lancet (2023)

    Fulltext@MSK | Save
  • Gene-based confirmatory germline testing following tumor-only sequencing of prostate cancer
    Journal Article

    Truong, H.; Breen, K.; Nandakumar, S.; Sjoberg, D. D.; Kemel, Y.; Mehta, N.; Lenis, A. T.; Reisz, P. A.; Carruthers, J.; Benfante, N.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • Health state utility values and quality of life in patients receiving ripretinib in the phase 3 INVICTUS trial and a real-world evidence study in China
    Meeting Abstract

    Jones, R. L.; Blay, J. Y.; Chi, P.; Bauer, S.; Gelderblom, H.; Shen, L.; He, Y. L.; Heinrich, M. C.; Schöffski, P.; Zalcberg, J. R.; more...
    Value in Health (2022)

    Fulltext@MSK | Save
  • Distinct IDH1/2-associated methylation profile and enrichment of TP53 and TERT mutations distinguish dedifferentiated chondrosarcoma from conventional chondrosarcoma on integrated genomic and epigenomic profiling
    Meeting Abstract

    Dermawan, J.; Nafa, K.; Mohanty, A.; Xu, Y.; Rijo, I.; Villafania, L.; Benhamida, J.; Kelly, C.; Tap, W.; Boland, P.; more...
    Journal of Molecular Diagnostics (2022)

    Fulltext@MSK | Save
  • Validation of a germline genetic testing panel for hematologic malignancies using nail specimens
    Meeting Abstract

    Ceyhan-Birsoy, O.; Rana, S.; Rai, V.; Li, Y.; Yang, C.; Yelskaya, Z.; Rijo, I.; Casanova, J.; Somar, J.; Salazar, P.; more...
    Journal of Molecular Diagnostics (2022)

    Fulltext@MSK | Save
  • Inherited TP53 variants and risk of prostate cancer
    Journal Article

    Maxwell, K. N.; Cheng, H. H.; Powers, J.; Gulati, R.; Ledet, E. M.; Morrison, C.; Le, A.; Hausler, R.; Stopfer, J.; Hyman, S.; more...
    European Urology (2022)

    Fulltext@MSK | Save
  • Clinical utility and performance of an ultrarapid multiplex RNA-based assay for detection of ALK, ROS1, RET, and NTRK1/2/3 rearrangements and MET exon 14 skipping alterations
    Journal Article

    Chu, Y. H.; Barbee, J.; Yang, S. R.; Chang, J. C.; Liang, P.; Mullaney, K.; Chan, R.; Salazar, P.; Benayed, R.; Offin, M.; more...
    Journal of Molecular Diagnostics (2022)

    Fulltext@MSK | Save
  • Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: A multicentre, single-arm, phase 2 trial
    Journal Article

    Soumerai, J. D.; Mato, A. R.; Dogan, A.; Seshan, V. E.; Joffe, E.; Flaherty, K.; Carter, J.; Hochberg, E.; Barnes, J. A.; Hamilton, A. M.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save